Hysteroscopic system

Information

  • Patent Grant
  • 10251539
  • Patent Number
    10,251,539
  • Date Filed
    Friday, September 4, 2015
    9 years ago
  • Date Issued
    Tuesday, April 9, 2019
    6 years ago
Abstract
A hysteroscopy system includes a scope having an internal channel, a sheath removably coupled to the scope, and an outflow channel. The sheath has a distal flange extending internally towards an outer surface of the scope. The outflow channel is formed between an inner surface of the sheath and an outer surface of the scope. The distal flange forms a distal end of the outflow channel and is generally located between the scope and the sheath.
Description
FIELD OF THE INVENTION

The present invention relates generally to hysteroscopy systems, and, more particularly, to a hysteroscopy system having a small size for use in an office setting.


BACKGROUND OF THE INVENTION

Hysteroscopy refers generally to the inspection of a uterine cavity using a hysteroscope with access through the cervix. As such, hysteroscopy allows diagnosis of intrauterine pathology and, furthermore, can be used for surgical intervention. The hysteroscope typically includes a scope and a sheath.


One problem associated with some current hysteroscopy systems is that they must be used in an operating room setting with the patient being under some type of anesthesia. Anesthesia is required in particular because the size of current hysteroscopes is large and, as such, they can cause discomfort and pain to the patient. For example, a typical hysteroscope may have an outermost diameter of about 9 millimeters. Such hysteroscopes include a scope having a diameter of about 8 millimeters and a sheath having a diameter of about 9 millimeters. In comparison, scientific literature on the subject agrees that hysteroscopy can be performed using a vaginoscopic approach, which can be performed in an office setting, only when the outermost diameter of the hysteroscope is about 6 millimeters or less.


Another problem associated with current scopes is that they typically include a blunt flange at the scope distal end. The flange extends outwardly from the scope and make it difficult, if not impossible, to use the scope without the sheath and/or without an obturator. Accordingly, the size of some current hysteroscopes is limited to the size of the scope and the sheath, .e.g., a diameter of 9 millimeters.


What is needed, therefore, is a hysteroscope system for an office setting that addresses the above-stated and other problems.


SUMMARY OF THE INVENTION

According to one aspect of the present invention, a hysteroscopy system is directed to performing a medical procedure in an office setting. The hysteroscopy system includes a scope having an outer surface, an internal channel defined by an inner surface, and a distal end. A sheath is removably coupled to the scope and has a tip at which a distal flange extends internally towards the outer surface of the scope. The sheath also has an inner surface and a plurality of outflow holes near the distal flange. An outflow channel is formed between the inner surface of the sheath and the outer surface of the scope, the distal flange forming a distal end of the outflow channel. An operative channel is formed within the internal channel of the scope for receiving at least one of a surgical tool and an inflow fluid, and a visualization channel is formed adjacent to the operative channel for receiving a visualization device.


According to yet another aspect of the invention, a hysteroscopy system for a medical procedure includes a scope in the form of an elongated tubular member having an outer surface and an internal surface. The internal surface of the scope defines an internal channel of the scope. A sheath is in the form of an elongated tubular member removably coupled to the scope, the sheath having an outer surface and an internal surface. The sheath has a flange extending internally towards the outer surface of the scope at a distal end of the sheath. An operative member is located within the internal channel of the scope and is in the form of an elongated D-shape tubular member. The operative member has an outer surface and an internal surface, the outer surface being spaced away from the internal surface of the scope to form a visualization channel.


According to yet another aspect of the invention, a hysteroscopy system includes a scope having an outer surface and an internal channel, and a sheath removably coupled to the scope. The sheath has an inner surface and a distal flange, the distal flange extending internally towards the outer surface of the scope. An outflow channel is formed between the inner surface of the sheath and the outer surface of the scope, the distal flange forming a distal end of the outflow channel between the scope and the sheath.


Additional aspects of the invention will be apparent to those of ordinary skill in the art in view of the detailed description of various embodiments, which is made with reference to the drawings, a brief description of which is provided below.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of a hysteroscope system.



FIG. 2A is an enlarged perspective view of a distal end of the hysteroscope system.



FIG. 2B is an enlarged side view of the distal end of the hysteroscope system.



FIG. 2C is an enlarged cross-sectional end view of the distal end of the hysteroscope system.



FIG. 2D is an enlarged cross-sectional top view of the distal end of the hysteroscope system.



FIG. 3 shows dimensions associated with the distal end of FIG. 2A.



FIG. 4 is a perspective view of the hysteroscope system having a sheath removed from a scope.



FIG. 5 is an enlarged perspective view of the distal end of the hysteroscope system of FIG. 4.



FIG. 6 is a perspective view of an alternative embodiment of the hysteroscope system.





While the invention is susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and will be described in detail herein. It should be understood, however, that the invention is not intended to be limited to the particular forms disclosed. Rather, the invention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the appended claims.


DETAILED DESCRIPTION

Referring to FIG. 1, a hysteroscope system 100 includes a hysteroscope 102 having, inter alia, a sheath 104, an inflow valve 106, an outflow valve 108, a light post 110, and a morcellator 112. The sheath 104 is a generally an elongated tubular member that has a distal end 114 and a proximal end 116. The hysteroscope system 100 also includes an arm 117 that is connected to an imaging device (e.g., a camera) to capture images received via a visualization device (e.g., visualization device 124).


According to some exemplary embodiments, the hysteroscope system 100 is intended for morcellation of uterine pathology with a scope and accessories having a sufficiently small diameter that can be inserted into a patient's uterus using the vaginoscopic approach. In particular, the hysteroscope system 100 provides a way to minimize patient pain because a tenanculum and speculum are not typically used.


Furthermore, anesthesia is not needed and the medical procedures can be performed in an office setting. This may result, for example, in a quicker surgery with less pain and quicker recovery, and may potentially lower the cost of the surgery. Yet another advantage of the hysteroscope system 100 is that a surgeon has the option to decide if they prefer greater flow instruments (e.g., with a coupled sheath 104) or smaller diameter instruments (e.g., with a removed sheath 104), depending on the patient case.


Referring to FIG. 2A, the sheath 104 is removably coupled to a scope 118, which is generally an elongated tubular member having (similar to the sheath 104) a distal end 114 and a proximal end 116. More specifically, the sheath 104 is slidably fitted in an overlapping manner over the scope 118. The scope 118 includes an operative member 120, which is in the form of an elongated D-shape tubular member.


The operative member 120 receives internally a surgical tool 122, which can be selected from a variety of different tools. For example, the surgical tool 122 can be a rotary morcellator, a reciprocating morcellator, or a morcellator having both reciprocal and rotary capabilities. The scope 118 further includes a visualization device 124. The visualization device 124 is adjacent to the operative member 120 and can include various image devices. For example, the visualization device 124 can include fiber-optic technology for illumination and image transmission.


To maintain continuous outflow, a plurality of outflow holes 126 are formed near the distal end 114 of the sheath 104. The inflow valve 106 (shown in FIG. 1) regulates inflow of a liquid through the operative member 120, as represented by the arrows 107 extending from the operative member 120. The liquid is used, for example, to distend and irrigate the uterus of a patient. Furthermore, the liquid is generally received from an access pump, which delivers the fluid to produce a substantially constant predetermined pressure level within a joint cavity, e.g., a uterus. The outflow valve 108 (shown in FIG. 1) regulates outflow of the liquid through the outflow holes 126 via an outflow channel 128 (shown in FIG. 2C) formed between the sheath 104 and the scope 118. The outflow of the liquid is represented by the arrows 109 extending into the outflow holes 126. The outflow liquid is generally sent to a waste container.


Referring to FIG. 2B, the sheath 104 has at the distal end 114 a flange 130 extending inwardly towards the scope 118 to form a closed end of the outflow channel 128 (shown in FIG. 2C). The flange 130 has a generally oval shape and includes two pairs of opposite sides 130a-130d.


According to the illustrated embodiment, the shape of the flange 130 is non-uniform. For example, a second side 130b extends a greater distance internally towards the center of the scope 118 than a first side 130a. Similarly, based on the symmetric features of this embodiment, a fourth side 130d extends a greater distance internally towards the center of the scope 118 than a third side 130c. In alternative embodiments, the flange 130 can have different shapes and sizes.


Referring to FIGS. 2C-2D, the sheath 104 has an outer surface 104a and an internal surface 104b, and the scope 118 has an outer surface 118a and an internal surface 118b. The internal surface 104b of the sheath 104 defines an internal channel in which the scope 118 and the visualization device 124 are located. The internal surface 118b of the scope 118 defines an internal channel in which the outer member and thus the surgical tool 122 is located.


The operative member 120 has an outer surface 120a, an internal surface 120b, and a flat outer surface 120c (clearly shown in FIG. 2C). The flat outer surface 120c is spaced away from the internal surface 118b of the scope 118 to form a visualization channel 132 (clearly shown in FIG. 2C) in which the visualization device 124 is located. The visualization channel 132 is only a small part of the larger internal channel of the scope 118.


The outflow channel 128 is formed between the internal surface 104b of the sheath 104 and the outer surface 118a of the scope 118. An inflow channel 134 is formed in the internal channel of the scope 118. If the surgical tool 122 is removed, the inflow channel 134 is simply the entire internal channel of the scope 118. If the surgical tool 122 is in place, the inflow channel 134 is limited to the area between the surgical tool 122 and the internal surface 120b of the operative member 120.


Referring to FIG. 3, the hysteroscopy system 100 is designed to have a size that can be used in an office setting. Specifically, the outer most diameter is designed to be about 6 millimeters or less. According to the illustrated embodiment, the outer diameter D1 of the sheath 104 (which is the same as the diameter of the outer surface 104b) is about 5.6 millimeters. For example, in an alternative embodiment the diameter of the sheath 104 is 5.5 millimeters. The outer diameter D2 of the surgical tool 122 (e.g., morcellator) is about 2.9 millimeters.


The scope 118 has an oval shape with a long diameter D3 of about 5.15 millimeters and a short diameter D4 of about 4.6 millimeters. The operative member 120 has a curvature dimension L1 of about 3.1 millimeters and a flat dimension L2 of about 3.95 millimeters.


The relatively small dimensions of the hysteroscopy system 100 allows a patient to be treated in an office setting. Generally, medical procedures may be provided to a patient with the use of the current hysteroscopy system 100 such that little or no anesthesia may be necessary. Clearly, one advantage of the hysteroscopy system 100 is that it is sufficiently small in diameter to be suitable for the vaginoscopic approach.


Referring to FIG. 4, the hysteroscopy system 100 is also usable without the sheath 104 while still providing continuous flow via a diagnostic cannula 135 (e.g., a cannula having a diameter of about 2.9 millimeters). Specifically, the sheath 104 is removed to allow only the insertion of the scope 118 into a patient, e.g., into an uterus. The removal of the sheath 104 decreases the outermost diameter of the hysteroscopy system 100. For example, in accordance with the dimensions described above in reference to FIG. 3, the outermost diameter decreases to about 5.15 millimeters (the long diameter D3) from about 5.6 millimeters (the outer diameter D1). When the sheath 104 is removed, the outflow can be provided by an operation tool, such as the morcellator 112 described above (shown in FIGS. 1-3), or by the diagnostic cannula 135.


In contrast to previous scopes, the scope 118 does not have a flange extending outwards from its distal end. The outward extending flange of the previous scopes unnecessarily increased the outermost diameter of the respective scopes and created an obtrusive distal end that made it difficult, if not impossible, to introduce into a patient without a sheath and obturator.


Referring to FIG. 5, the hysteroscopy system can be used for diagnostic purposes when the sheath 104 is removed. The sheath 104 is likely to be used in operative cases mostly to clear the visual field before introduction of a morcellator blade. The diagnostic cannula 135, which has a distal end 136, is used to create a smaller overall diameter of the system for diagnostic purposes. According to the dimensions described above, a reduction of approximately 0.5 millimeters can be achieved by removing the sheath 104. Another advantage of the cannula 135 is that it can be made reusable. Yet another advantage of the cannula 135 is that it can be used to distend and irrigate the patient's uterus during the diagnostic procedure.


The cannula 135 allows for continuous outflow but does not extend beyond the distal end of the scope 118. For example, the cannula 135 provides a replacement for the outflow channel 128, which is removed with the removal of the sheath 104. Specifically, the cannula 135 provides an alternative outflow channel 138 to replace the outflow channel 128 formed by the sheath 104. As such, continuous flow can be maintained even if the sheath 104 is removed.


Referring to FIG. 6, the hysteroscope system 100 alternatively includes a flow device 140 inserted within the operative member 120. The flow device 140 has an inflow tubular element 142 and an outflow tubular element 144, which can be conjoined elements or separate elements.


The distal ends of the tubular elements 142, 144 terminate at different points within the operative member 120. Preferably, the distal end of the inflow tubular element 142 terminates at the distal end 114 of the scope 118, and the distal end of the outflow tubular element 144 terminates some distance away from the distal end 114 within the operative member 120. The termination of tubular elements 142, 144 at different points along the operative member 120 eliminates the possibility of fluid short-circuit and provides better circulation and, hence, irrigation within the uterus.


According to one example, the flow device 140 is made of stainless steel and, as such, can be a reusable device. According to another example, the flow device 140 is made from a much more cost-effective material, such as a polymer. If a polymer is used, the flow device 140 will typically be considered a single-use device.


In practice, for example, a surgeon will insert the flow device 140 into the operative member 120 of the hysteroscope 102 prior to introduction into the uterus of a patient. After hysteroscope introduction into the uterus, an inflow valve 146 of the flow device 140 will be opened and the uterus will be distended. Then, by opening an outflow valve 148 of the flow device 140, irrigation is achieved. In the case of a diagnostic procedure, the flow device 140 could stay in place for the duration of the surgery. In the case of an operative procedure, the flow device 140 is removed and an operative tool (e.g., the morcellator 112) is inserted into the scope 118.


While the best modes for carrying out the present invention have been described in detail, those familiar with the art to which this invention relates will recognize various alternative designs and embodiments for practicing the invention within the scope of the appended claims. For example, the sheath 104, the scope 118, and the surgical tool 122 can be circular, oval, or any other smooth shape (i.e., an unobtrusive shape such as a shape that does not have a outward extending flange). In another example, the operative member 120 can have a circular shape or any other similar shape to the illustrated D-shape.

Claims
  • 1. A hysteroscopy system comprising: a scope having an outer surface and an inner surface, the outer surface having a uniform cross section along a length of the scope;an operative member within the scope having an outer surface and an inner surface, the inner surface defining an operative channel, and at least part of the outer surface of the operative member and the inner surface of the scope defining a visualization channel; anda sheath removably coupled to and surrounding the scope, the sheath including a tube defining a longitudinal axis, a distal end of the tube being in a shape of a flange extending perpendicular relative to the longitudinal axis towards the outer surface of the scope, wherein the outer surface of the scope and an inner surface of the tube form an outflow channel, and the flange abuts the outer surface of the scope to form an end of the outflow channel.
  • 2. The hysteroscopy system of claim 1, wherein a radial cross section of the outer surface of the scope at a distal end of the scope forms a shape with flat symmetrical sides between arcuate symmetrical sides.
  • 3. The hysteropscopy system of claim 1, wherein the visualization channel is configured to receive a visualization device.
  • 4. The hysteroscopy system of claim 1, wherein an outer diameter of the sheath is about 5.6 millimeters.
  • 5. The hysteroscopy system of claim 4, wherein an outer diameter of the scope is about 4.6 to 5.15 millimeters.
  • 6. The hysteroscopy system of claim 1, wherein a radial cross section of the operative member forms a horizontal D-shape.
  • 7. The hysteroscopy system of claim 1, further comprising a surgical tool within the operative channel.
CROSS-REFERENCE TO RELATED APPLICATION

The present application is a continuation of U.S. patent application Ser. No. 12/892,355, filed Sep. 28, 2010, now allowed, which is hereby incorporated by reference herein in its entirety.

US Referenced Citations (275)
Number Name Date Kind
1585934 Muir May 1926 A
1666332 Hirsch Apr 1928 A
1831786 Duncan Nov 1931 A
2708437 Hutchins May 1955 A
3297022 Wallace Jan 1967 A
3686706 Finley Aug 1972 A
3734099 Bender May 1973 A
3791379 Storz Feb 1974 A
3812855 Banko May 1974 A
3835842 Iglesias Sep 1974 A
3850162 Iglesias Nov 1974 A
3945375 Banko Mar 1976 A
3980252 Tae Sep 1976 A
3995619 Glatzer Dec 1976 A
3996921 Neuwirth Dec 1976 A
4011869 Seiler, Jr. Mar 1977 A
4108182 Hartman Aug 1978 A
4146405 Timmer Mar 1979 A
4198958 Utsugi Apr 1980 A
4203444 Bonnell May 1980 A
4210146 Banko Jul 1980 A
4246902 Martinez Jan 1981 A
4247180 Norris Jan 1981 A
4258721 Parent Mar 1981 A
4261346 Wettermann Apr 1981 A
4294234 Matsuo Oct 1981 A
4316465 Dotson, Jr. Feb 1982 A
4369768 Vukovic Jan 1983 A
4392485 Hiltebrandt Jul 1983 A
4414962 Carson Nov 1983 A
4449538 Corbitt May 1984 A
4493698 Wang Jan 1985 A
4517977 Frost May 1985 A
4543965 Pack Oct 1985 A
4567880 Goodman Feb 1986 A
4589414 Yoshida May 1986 A
4601284 Arakawa Jul 1986 A
4601290 Effron Jul 1986 A
4606330 Bonnet Aug 1986 A
4630598 Bonnet Dec 1986 A
4644952 Patipa Feb 1987 A
4649919 Thimsen Mar 1987 A
4700694 Shishido Oct 1987 A
4706656 Kuboto Nov 1987 A
4718291 Wood Jan 1988 A
4737142 Heckele Apr 1988 A
4749376 Kensey Jun 1988 A
4756309 Sachse Jul 1988 A
4819635 Shapiro Apr 1989 A
4844064 Thimsen Jul 1989 A
4850354 McGurk-Burleson Jul 1989 A
4856919 Takeuchi Aug 1989 A
4867157 McGurk-Burleson Sep 1989 A
4924851 Ognier May 1990 A
4940061 Terwilliger Jul 1990 A
4950278 Sachse Aug 1990 A
4955882 Hakky Sep 1990 A
4986827 Akkas Jan 1991 A
4998527 Meyer Mar 1991 A
4998914 Wiest Mar 1991 A
5007917 Evans Apr 1991 A
5027792 Meyer Jul 1991 A
5037386 Marcus Aug 1991 A
5105800 Takahashi Apr 1992 A
5106364 Hayafuji Apr 1992 A
5112299 Pascaloff May 1992 A
5116868 Chen May 1992 A
5125910 Freitas Jun 1992 A
5133713 Huang Jul 1992 A
5152744 Krause Oct 1992 A
5158553 Berry Oct 1992 A
5163433 Kagawa Nov 1992 A
5169397 Sakashita Dec 1992 A
5176677 Wuchinich Jan 1993 A
5195541 Obenchain Mar 1993 A
5226910 Kajiyama Jul 1993 A
5244459 Hill Sep 1993 A
5254117 Rigby Oct 1993 A
5269785 Bonutti Dec 1993 A
5270622 Krause Dec 1993 A
5275609 Pingleton Jan 1994 A
5288290 Brody Feb 1994 A
5304118 Trese Apr 1994 A
5312399 Hakky May 1994 A
5312425 Evans May 1994 A
5312430 Rosenbluth May 1994 A
5320091 Grossi Jun 1994 A
5347992 Pearlman Sep 1994 A
5350390 Sher Sep 1994 A
5364395 West, Jr. Nov 1994 A
5374253 Burns, Sr. Dec 1994 A
5390585 Ryuh Feb 1995 A
5392765 Muller Feb 1995 A
5395313 Naves Mar 1995 A
5403276 Schechter Apr 1995 A
5409013 Clement Apr 1995 A
5409453 Lundquist Apr 1995 A
5411513 Ireland May 1995 A
5421819 Edwards Jun 1995 A
5425376 Banys Jun 1995 A
5429601 Conley Jul 1995 A
5435805 Edwards Jul 1995 A
5443476 Shapiro Aug 1995 A
5449356 Walbrink Sep 1995 A
5456673 Ziegler Oct 1995 A
5456689 Kresch Oct 1995 A
5483951 Frassica Jan 1996 A
5490819 Nicholas Feb 1996 A
5490860 Middle Feb 1996 A
5492537 Vancaillie Feb 1996 A
5498258 Hakky Mar 1996 A
5527331 Kresch Jun 1996 A
5549541 Muller Aug 1996 A
5556378 Storz Sep 1996 A
5563481 Krause Oct 1996 A
5569164 Lurz Oct 1996 A
5569254 Carlson Oct 1996 A
5569284 Young Oct 1996 A
5575756 Karasawa Nov 1996 A
5591187 Dekel Jan 1997 A
5601583 Donahue Feb 1997 A
5601603 Illi Feb 1997 A
5602449 Krause Feb 1997 A
5603332 O'Connor Feb 1997 A
5630798 Beiser May 1997 A
5649547 Ritchart Jul 1997 A
5669927 Boebel Sep 1997 A
5672945 Krause Sep 1997 A
5674179 Bonnet Oct 1997 A
5676497 Kim Oct 1997 A
5695448 Kimura Dec 1997 A
5702420 Sterling Dec 1997 A
5709698 Adams Jan 1998 A
5730752 Alden Mar 1998 A
5733298 Berman Mar 1998 A
5741286 Recuset Apr 1998 A
5741287 Alden Apr 1998 A
5749885 Sjostrom May 1998 A
5749889 Bacich May 1998 A
5759185 Grinberg Jun 1998 A
5772634 Atkinson Jun 1998 A
5775333 Burbank Jul 1998 A
5782849 Miller Jul 1998 A
5807240 Muller Sep 1998 A
5807282 Fowler Sep 1998 A
5810770 Chin Sep 1998 A
5810861 Gaber Sep 1998 A
5814009 Wheatman Sep 1998 A
5833643 Ross Nov 1998 A
5840060 Beiser Nov 1998 A
5857995 Thomas Jan 1999 A
5873886 Larsen Feb 1999 A
5899915 Saadat May 1999 A
5911699 Anis Jun 1999 A
5911722 Adler Jun 1999 A
5913867 Dion Jun 1999 A
5916229 Evans Jun 1999 A
5925055 Adrian Jul 1999 A
5928163 Roberts Jul 1999 A
5944668 Vancaillie Aug 1999 A
5947990 Smith Sep 1999 A
5951490 Fowler Sep 1999 A
5956130 Vancaillie Sep 1999 A
5957832 Taylor Sep 1999 A
6001116 Heisler Dec 1999 A
6004320 Casscells Dec 1999 A
6007513 Anis Dec 1999 A
6024751 Lovato Feb 2000 A
6032673 Savage Mar 2000 A
6039748 Savage Mar 2000 A
6042552 Cornier Mar 2000 A
6068641 Varsseveld May 2000 A
6086542 Glowa Jul 2000 A
6090094 Clifford Jul 2000 A
6090123 Culp Jul 2000 A
6113594 Savage Sep 2000 A
6119973 Galloway Sep 2000 A
6120147 Vijfvinkel Sep 2000 A
6120462 Hibner Sep 2000 A
6132448 Perez Oct 2000 A
6149633 Maaskamp Nov 2000 A
6156049 Lovato Dec 2000 A
6159160 Hsei Dec 2000 A
6159209 Hakky Dec 2000 A
6203518 Anis Mar 2001 B1
6217543 Anis Apr 2001 B1
6224603 Marino May 2001 B1
6244228 Kuhn Jun 2001 B1
6258111 Ross Jul 2001 B1
6277096 Cortella Aug 2001 B1
6315714 Akiba Nov 2001 B1
6358200 Grossi Mar 2002 B1
6358263 Mark Mar 2002 B2
6359200 Day Mar 2002 B1
6402701 Kaplan Jun 2002 B1
6428486 Ritchart Aug 2002 B2
6443947 Marko Sep 2002 B1
6471639 Rudischhauser Oct 2002 B2
6494892 Ireland Dec 2002 B1
6585708 Maaskamp Jul 2003 B1
6610066 Dinger Aug 2003 B2
6626827 Felix Sep 2003 B1
6632182 Treat Oct 2003 B1
6656132 Ouchi Dec 2003 B1
6712773 Viola Mar 2004 B1
6824544 Boebel Nov 2004 B2
6837847 Ewers Jan 2005 B2
7025720 Boebel Apr 2006 B2
7025732 Thompson Apr 2006 B2
7150713 Shener Dec 2006 B2
7226459 Cesarini Jun 2007 B2
7249602 Emanuel Jul 2007 B1
7510563 Cesarini Mar 2009 B2
7763033 Gruber Jul 2010 B2
7922737 Cesarini Apr 2011 B1
8061359 Emanuel Nov 2011 B2
8062214 Shener Nov 2011 B2
8419626 Shener-Irmakoglu Apr 2013 B2
8663264 Cesarini Mar 2014 B2
8678999 Isaacson Mar 2014 B2
8852085 Shener-Irmakoglu Oct 2014 B2
8893722 Emanuel Nov 2014 B2
8932208 Kendale Jan 2015 B2
8951274 Adams Feb 2015 B2
9060800 Cesarini Jun 2015 B1
9060801 Cesarini Jun 2015 B1
9066745 Cesarini Jun 2015 B2
9072431 Adams Jul 2015 B2
9089358 Emanuel Jul 2015 B2
9125550 Shener-Irmakoglu Sep 2015 B2
9155454 Sahney Oct 2015 B2
20010039963 Spear Nov 2001 A1
20010047183 Privitera Nov 2001 A1
20020058859 Brommersma May 2002 A1
20020165427 Yachia Nov 2002 A1
20030050603 Todd Mar 2003 A1
20030050638 Yachia Mar 2003 A1
20030078609 Finlay Apr 2003 A1
20030114875 Sjostrom Jun 2003 A1
20040204671 Stubbs Oct 2004 A1
20050043690 Todd Feb 2005 A1
20050085692 Kiehn Apr 2005 A1
20050234298 Kucklick Oct 2005 A1
20060036132 Renner Feb 2006 A1
20060047185 Shener et al. Mar 2006 A1
20060241586 Wilk Oct 2006 A1
20070073101 Queyroux et al. Mar 2007 A1
20080015621 Emanuel Jan 2008 A1
20080058588 Emanuel Mar 2008 A1
20080058842 Emanuel Mar 2008 A1
20080097468 Adams Apr 2008 A1
20080097469 Gruber Apr 2008 A1
20080097470 Gruber Apr 2008 A1
20080097471 Adams Apr 2008 A1
20080135053 Gruber Jun 2008 A1
20080146872 Gruber Jun 2008 A1
20080146873 Adams Jun 2008 A1
20080245371 Gruber Oct 2008 A1
20080249366 Gruber Oct 2008 A1
20080249534 Gruber Oct 2008 A1
20080249553 Gruber Oct 2008 A1
20080262308 Prestezog Oct 2008 A1
20090012362 Kucklick Jan 2009 A1
20090082628 Kucklick et al. Mar 2009 A1
20090270812 Litscher Oct 2009 A1
20090270895 Churchill Oct 2009 A1
20090270896 Sullivan Oct 2009 A1
20090270897 Adams Oct 2009 A1
20090270898 Chin Oct 2009 A1
20100087798 Adams Apr 2010 A1
20100152647 Shener Jun 2010 A1
20110166419 Reif Jul 2011 A1
20120078038 Sahney Mar 2012 A1
20130131452 Kuroda May 2013 A1
20140031834 Germain Jan 2014 A1
Foreign Referenced Citations (74)
Number Date Country
1695546 Nov 2005 CN
101662993 Mar 2010 CN
3339322 May 1984 DE
3206381 Jul 1986 DE
3601453 Sep 1986 DE
3615694 Nov 1987 DE
4038398 Jun 1992 DE
4440035 May 1996 DE
19633124 May 1997 DE
19751632 Sep 1999 DE
102006022827 Dec 2006 DE
0310285 Apr 1989 EP
0327410 Aug 1989 EP
0557044 Aug 1993 EP
0582295 Feb 1994 EP
0606531 Jul 1994 EP
0621008 Oct 1994 EP
0806183 May 1997 EP
1681022 Jul 2006 EP
2093353 Sep 1982 GB
2311468 Oct 1997 GB
2001-75416 May 1989 JP
2002 529185 Sep 2002 JP
2002 538889 Nov 2002 JP
2003 245247 Sep 2003 JP
2005319086 Nov 2005 JP
1006944 Mar 1999 NL
WO 198101648 Jun 1981 WO
WO 199211816 Jul 1992 WO
WO 199307821 Apr 1993 WO
WO 199315664 Aug 1993 WO
WO 199426181 Nov 1994 WO
WO 199505777 Mar 1995 WO
WO 199510981 Apr 1995 WO
WO 199510982 Apr 1995 WO
WO 199522935 Aug 1995 WO
WO 199530377 Nov 1995 WO
WO 199611638 Apr 1996 WO
WO 199626676 Sep 1996 WO
WO 199709922 Mar 1997 WO
WO 199717027 May 1997 WO
WO 199719642 Jun 1997 WO
WO 199724071 Jul 1997 WO
WO 199734534 Sep 1997 WO
WO 199735522 Oct 1997 WO
WO 199809569 Mar 1998 WO
WO 199810707 Mar 1998 WO
WO 199846147 Oct 1998 WO
WO 199903407 Jan 1999 WO
WO 199903409 Jan 1999 WO
WO 199907295 Feb 1999 WO
WO 199911184 Mar 1999 WO
WO 199939648 Aug 1999 WO
WO 199944506 Sep 1999 WO
WO 199960935 Dec 1999 WO
WO 200012010 Mar 2000 WO
WO 200028890 May 2000 WO
WO 200033743 Jun 2000 WO
WO 200044295 Aug 2000 WO
WO 200047116 Aug 2000 WO
WO 200057797 Oct 2000 WO
WO 200135831 May 2001 WO
WO 200158368 Aug 2001 WO
WO 200195810 Dec 2001 WO
WO 2002069808 Sep 2002 WO
WO 2003022164 Mar 2003 WO
WO 2003077767 Sep 2003 WO
WO 2005060842 Jul 2005 WO
WO 2005096963 Oct 2005 WO
WO 2006105283 Oct 2006 WO
WO 2006121968 Nov 2006 WO
WO 2006121970 Nov 2006 WO
WO 2007044833 Apr 2007 WO
WO 2012044705 Apr 2012 WO
Non-Patent Literature Citations (133)
Entry
European examination report issued in corresponding EP application No. 11770261.3 dated Aug. 4, 2016.
Notification of Reason for Refusal issued in corresponding Korean application No. 10-2013-7008294 dated Dec. 14, 2017.
Chinese Office Action for Chinese Application No. 201180046921.6, dated Dec. 15, 2015, 3 pages, with English language translation.
Inquiry Made in Course of Substantive Examination for Russian Patent Application No. 2013119298/14(028553) dated Sep. 29, 2015, 5 pages, with English language translation.
ACMI Corporation, “Dolphin II Hysteroscopic Fluid Management Systems,” ACMI Corporation, 2002 (1 page).
ACMI Corporation, “Dolphin II and Disten-U-Flo Fluid Management Systems for Hysteroscopy”, ACMI Corporation, 2002 (1 page).
Bacsko “Uterine Surgery by Operative Hysteroscopy”, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 71, pp. 219-222, 1997 (4 pages).
Baggish et al., “Diagnostic and Operative Hysterectomy,” Mosby, pp. 97-105, 123-125, 127-132, 353-355, and 394-398, 1999 (27 pages).
Chinese Office Action for Chinese Application No. 201180046921.6, dated Dec. 23, 2014, 29 pages, with English language translation.
C.R. Bard, Inc, “The HydroFlex HD System” (1 page).
Cravello et al., “Hysteroscopic Resection of Fibroids: Results with a 6-Year Follow-up Period”, Journal of Gynecologic Surgery, vol. 15, No. 1, 1-5 1999 (5 pages).
Defendant Hologic Inc.'s Preliminary, Non-Binding List of Asserted Prior Art References, dated Feb. 8, 2012, in Smith & Nephew, Inc. v. Hologic, Inc., Civil Action Nos. 11-12064-RWZ and 10- 10951-RWZ, U.S. District Court for the District of Massachusetts (7 pages).
Dictionary definition of reciprocate, Merrian-Webster Dictionary, on-line edition, retrieved Mar. 20, 2013 (1 page).
Dictionary definition of rotate, Merriam-Webster Dictionary, on-line edition, retrieved Mar. 20, 2013 (1 page).
Dictionary definition of translate, Merriam-Webster Dictionary, on-line edition, retrieved Mar. 20, 2013 (1 page).
Drews et al., “Surgical Approach to Myomas: Laparoscopy and Hysteroscopy”, Seminars in Reproductive Endocrinology, vol. 10, No. 4, pp. 367-377, 1992 (11 pages).
Dumesic et al., “A New Approach to Hysteroscopic Cannulation of the Fallopian Tube”, Journal of Gynecologic Surgery, vol. 7, No. 1, pp. 7-9, 1991 (3 pages).
Emanuel et al., “Long-term Results of Hysteroscopic Myomectomy for Abnormal Uterine Bleeding”, Obstetrics & Gynecoogy, vol. 93, No. 5, Part I, pp. 743-748, 1999 (6 pages).
European Patent Application No. 05 786 521.4-2305, Examination Report dated Apr. 21, 2010 (4 pages).
European Patent Application No. 05 786 521.4-2305, Examination Report dated Sep. 26, 2012 (5 pages).
European Patent Application No. 11 770 261.3-1657, Examination Report dated Feb. 11, 2014 (4 pages).
Exhibit P to Hologic's Opposition to Smith & Nephew's Motion for Preliminary Injunction, Redacted, filed Dec. 30, 2011, in Smith & Nephew, Inc. v. Hologic, Inc., Civil Action No. 11-12064-RWZ, U.S. District Court for the District of Massachusetts (99 pages).
First Office Action for Japanese Patent Application No. 213-531779 dated May 18, 2015, with English translation, 6 pages.
Franchini et al., “Endometrial resection: a diagnostic tool in postmenopausal women”, Gynecological Endoscopy, 8, pp. 111-114, 1999 (5 pages).
“From Distention to Deficit Monitoring Taking the All-in-One Approach”, W.O.M. World of Medicine (1 page).
Gerber et al., “The Endoscapel: A new endoscopic instrument for supracervical hysterectomy and morcellation of masses; clinical evaluation”, European Journal of Obstetrics & Gynecology and Reproductive Biology, 86, p. S12, 1999 (1 page).
Gynecare “Motor Drive Unit” Instructions for Use (3 pages).
Gynecare X-Tract, “Tissue Morcellator”, Instructions for Use (3 pages).
Gynecare, “Fluid Management System” Instructions for Use (26 pages).
Gynescope Corporation “Laser Fiber Director”, Advertisement, Journal of Gynecologic Surgery, vol. 6, No. 1, 1990 (2 pages).
Hess et al., “Textbook of Bilio-Pancreatic Disease”, vol. III, Piccin, e.g. Fig 6.5.1, pp. 1584-1586, 1997 (5 pages).
Hologic's Opposition to Smith & Nephew's Motion for Preliminary Injunction, Redacted, filed Dec. 30, 2011, in Smith & Nephew, Inc. v. Hologic, Inc., Civil Action No. 11- 12064-RWZ, U.S. District Court for the District of Massachusetts (26 pages).
“HysteRo-Purator 1143-1 Technical Data” WISAP (2 pages).
International Application No. PCT/US2005/029807, International Preliminary Report on Patentability dated Feb. 28, 2007 (9 pages).
International Application No. PCT/US2005/029807, International Search Report dated Jun. 13, 2006 (5 pages).
International Application No. PCT/US2011/053753, International Preliminary Report on Patentability dated Apr. 2, 2013 (7 pages).
International Application No. PCT/US2011/053753, International Search Report dated Dec. 20, 2011 (4 pages).
Japanese Patent Application No. 2007-530014, Translation of Office Action dated Feb. 15, 2011 (10 pages).
Karl Storz “Pilot a Course to Successful Outcomes”, Intermetro Industries Corporation, 2001 (2 pages).
Karl Storz “Uterine Resectoscopes for Endometrial Ablation and Resection”, Advertisement, Journal of Gynecologic Surgery, vol. 6, No. 1, 1990 (3 pages).
Karl Storz, Advertisement, Journal of Gynecologic Surgery, vol. 5, No. 4, 1989 (3 pages).
Lin et al. “Clinical Applications of a New Fujinon Operating Fiberoptic Hysteroscope”, Journal of Gynecologic Surgery, vol. 6, No. 2, pp. 81-87, 1990 (7 pages).
Mettler et al., “Pelviscopic uterine surgery” Surgical Endoscopy, 6, pp. 23-31, 1992 (9 pages).
Neis et al., “Hysteroscopy: Textbook and Atlas”, Thieme Medical Publishers, pp. 91-103, 1994 (13 pages).
Nisolle et al., “Endometrial ablation with the Nd-YAG laser in dysfunctional bleeding” Minimally Invasive Therapy, vol. 1, pp. 35-39, 1991 (5 pages).
Olympus Product Catalogue: Part No. A2461—OP Nephroscope, Sep. 1991 (3 pages).
Office Action in Chinese Patent Application No. 201180046921.6, dated Aug. 4, 2015, 13 pages.
Park et al., “Endoscopic Management of Uterine Myoma”, Yonsei Medical Journal, vol. 40, No. 6, pp. 583-588, 1999 (6 pages).
Patent Examination Report No. 1 for Australian Patent Application No. 2011308834 dated Jun. 11, 2015, 3 pages.
Reexamination No. 95/001,933, Action Closing Prosecution mailed Sep. 19, 2013 (41 pages).
Reexamination No. 95/001,933, Appendices 14-28 to Request for Inter Partes Reexamination of U.S. Pat. No. 7,226,459, Claim Charts for Various Claims in view of Various References (436 pages).
Reexamination No. 95/001,933, Appendix 2 to Request for Inter Partes Reexamination of U.S. Pat. No. 7,226,459, Memorandum of Decision dated Apr. 21, 2011, in Smith & Nephew, Inc. v. Interlace Medical, Inc., Civil Action No. 10-10951-RWZ, U.S. District Court for the District of Massachusetts (14 pages).
Reexamination No. 95/001,933, Appendix 6 to Request for Inter Partes Reexamination of U.S. Pat. No. 7,226,459, Opening Markman Brief of Plaintiff Smith & Nephew, Inc. dated Oct. 13, 2010, in Smith & Nephew, Inc. v. Interlace Medical, Inc., Civil Action No. 10-10951-RWZ, U.S. District Court for the District of Massachusetts (23 pages).
Reexamination No. 95/001,933, Appendix 7 to Request for Inter Partes Reexamination of U.S. Pat. No. 7,226,459, Defendant Interlace Medical, Inc's Responsive Markman Brief (Redacted) dated Oct. 27, 2010, in Smith & Nephew, Inc. v. Interlace Medical, Inc., Civil Action No. 10-10951-RWZ, U.S. District Court for the District of Massachusetts (26 pages).
Reexamination No. 95/001,933, Appendix 8 to Request for Inter Partes Reexamination of U.S. Pat. No. 7,226,459, Plaintiff Smith & Nephew, Inc.'s Reply in Support of Markman Brief dated Nov. 3, 2010, in Smith & Nephew, Inc. v. Interlace Medical, Inc., Civil Action No. 10-10951-RWZ, U.S. District Court for the District of Massachusetts (8 pages).
Reexamination No. 95/001,933, Examiner's Answer dated Mar. 25, 2015 (3 pages).
Reexamination No. 95/001,933, Executed Expert Declaration of Hal Walbrink in support of Request for Inter Partes Reexamination of U.S. Pat. No. 7,226,459, Executed Mar. 9, 2012 (42 pages).
Reexamination No. 95/001,933, First Office Action dated Jun. 5, 2012 (37 pages).
Reexamination No. 95/001,933, Litigation Search Report CRU 3999 dated Mar. 29, 2012 (24 pages).
Reexamination No. 95/001,933, Order Granting Request for Reexamination dated Jun. 5, 2012 (29 pages).
Reexamination No. 95/001,933, Patent Owner's Apr. 14, 2014 Appeal Brief (334 pages).
Reexamination No. 95/001,933, Patent Owner's Feb. 13, 2014 Notice of Appeal (2 pages).
Reexamination No. 95/001,933, Patent Owner's Aug. 6, 2012 Response to First Office Action dated Jun. 5, 2012 (156 pages).
Reexamination No. 95/001,933, Patent Owner's Jun. 3, 2013 Response to Second Office Action dated Apr. 1, 2013 (37 pages).
Reexamination No. 95/001,933, Patent Owner's Oct. 21, 2013 Response to Action Closing Prosecution dated Sep. 19, 2013 (180 pages).
Reexamination No. 95/001,933, Right of Appeal Notice mailed Jan. 14, 2014 (58 pages).
Reexamination No. 95/001,933, Second Office Action dated Apr. 1, 2013 (56 pages).
Reexamination No. 95/001,933, Third Party's Dec. 19, 2012 Response to Notification of Defective Paper and Comments on First Office Action dated Jun. 5, 2012 (38 pages).
Reexamination No. 95/001,933, Third Party's Jul. 3, 2013 Comments on Second Office Action dated Apr. 1, 2013 (62 pages).
Reexamination No. 95/001,933, Third Party's Mar. 12, 2012 Request for Inter Partes Reexamination of U.S. Pat. No. 7,226,459 (130 pages).
Reexamination No. 95/001,933, Third Party's May 14, 2014 Respondent's Brief (303 pages).
Reexamination No. 95/001,933, Third Party's Nov. 20, 2013 Comments on Action Closing Prosecution mailed Sep. 19, 2013 (38 pages).
Reexamination No. 95/001,933, Third Party's Sep. 5, 2012 Comments on First Office Action dated Jun. 5, 2012 (210 pages).
Reexamination No. 95/001,955, Appendix 19 to Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Opening Claim Construction Brief of Defendant Hologic, Inc., dated Feb. 24, 2012, in Smith & Nephew, Inc. v. Hologic, Inc., Civil Action No. 11-12064-RWZ, U.S. District Court for the District of Massachusetts (24 pages).
Reexamination No. 95/001,955, Appendix 20 to Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Opening Markman Brief of Plaintiff Smith & Nephew, Inc., dated Feb. 24, 2012, in Smith & Nephew, Inc. v. Hologic, Inc., Civil Action No. 11-12064-RWZ, U.S. District Court for the District of Massachusetts (24 pages).
Reexamination No. 95/001,955, Appendix 28 to Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Claim chart for anticipation of claims 1-8 based on U.S. Pat. No. 5,456,689 to Kresch (4 pages).
Reexamination No. 95/001,955, Appendix 29 to Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Claim chart for anticipation of claims 1-8 based on U.S. Pat. No. 6,032,673 to Savage (13 pages).
Reexamination No. 95/001,955, Appendix 30 to Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Claim chart for anticipation of claims 1-8 based on U.S. Pat. No. 3,945,375 to Banko (4 pages).
Reexamination No. 95/001,955, Decision Denying Petition dated Sep. 28, 2012 (5 pages).
Reexamination No. 95/001,955, Executed Expert Declaration of Dr. Henry A. Dominicis in support of Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Executed Apr. 1, 2012 (150 pages).
Reexamination No. 95/001,955, Executed Expert Declaration of Hal Walbrink in support of Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Executed Apr. 2, 2012 (22 pages).
Reexamination No. 95/001,955, Litigation Search Report CRU 3999 dated Apr. 3, 2012 (33 pages).
Reexamination No. 95/001,955, Order Denying Request for Inter Partes Reexamination mailed Jun. 4, 2012 (35 pages).
Reexamination No. 95/001,955, Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, filed Apr. 2, 2012 (265 pages).
Reexamination No. 95/001,955, Request for Reconsideration of Third Party Requestor's Petition for Reexamination mailed Jul. 3, 2012 (32 pages).
Reexamination No. 95/002,058, Executed Expert Declaration of Dr. Henry A. Dominicis in support of Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359, Executed Jul. 24, 2012 (101 pages).
Reexamination No. 95/002,058, First Action Closing Prosecution mailed Aug. 9, 2013 (34 pages).
Reexamination No. 95/002,058, First Office Action dated Sep. 19, 2012 (37 pages).
Reexamination No. 95/002,058, Litigation Search Report CRU 3999 dated Aug. 13, 2012 (29 pages).
Reexamination No. 95/002,058, Patent Owner's Mar. 5, 2015 Notice of Appeal (2 pages).
Reexamination No. 95/002,058, Patent Owner's Jan. 22, 2013 Response to First Office Action dated Sep. 19, 2012 (379 pages).
Reexamination No. 95/002,058, Patent Owner's Mar. 24, 2014 Response to Second Office Action dated Jan. 24, 2014 (55 pages).
Reexamination No. 95/002,058, Patent Owner's Sep. 29, 2014 Response to Second Action Closing Prosecution mailed Aug. 27, 2014 (12 pages).
Reexamination No. 95/002,058, Patent Owner's Sep. 9, 2013 Response to First Action Closing Prosecution dated Aug. 9, 2013 (159 pages).
Reexamination No. 95/002,058, Reexam Order dated Sep. 19, 2012 (54 pages).
Reexamination No. 95/002,058, Right of Appeal Notice mailed Feb. 4, 2015 (35 pages).
Reexamination No. 95/002,058, Second Action Closing Prosecution mailed Aug. 27, 2014 (35 pages).
Reexamination No. 95/002,058, Second Office Action dated Jan. 24, 2014 (31 pages).
Reexamination No. 95/002,058, Third Party's Apr. 23, 2014 Comments on Second Office Action mailed Jan. 24, 2014 (117 pages).
Reexamination No. 95/002,058, Third Party's Feb. 21, 2013 Comments on First Office Action mailed Sep. 19, 2012 (771 pages).
Reexamination No. 95/002,058, Third Party's Jul. 24, 2012 Request for Inter Partes Reexamination of U.S. Pat. No. 8,061,359 (1050 pages).
Reexamination No. 95/002,058, Third Party's Oct. 19, 2012 Request for Reconsideration of Certain Decisions Regarding Third Party Requestor's Request for Reexamination of U.S. Pat. No. 8,061,359 (19 pages).
Reexamination No. 95/002,058, Third Party's Oct. 29, 2014 Comments on Second Action Closing Prosecution mailed Aug. 27, 2014 (31 pages).
Reexamination No. 95/002,058, Third Party's Oct. 9, 2013 Comments on First Action Closing Prosecution mailed Aug. 9, 2013 (25 pages).
Reference AQ “Fishing Reel produced and sold by Shimano of Japan in to the U.S. prior to Oct. 26, 2001,” as cited in the IDS filed Oct. 17, 2005 in the prosecution file history of U.S. Appl. No. 09/983,810 (7 pages).
Richard Wolf “‘Morce—Power 2306’ Electronic Morcellator” (2 pages).
Richard Wolf “The Fluid Manager” (2 pages).
Sheth, “Fiberoptic Light for Oophorectomy at Vaginal Hysterectomy”, Journal of Gynecologic Surgery, vol. 14, No. 3, pp. 119-122, 1998 (4 pages).
Substantive Examination Report in the corresponding Patent Application No. MX/a/2013/003535, dated Aug. 20, 2015, 4 pages.
Sugimoto “A Color Atlas of Hysteroscopy” Springer-Verlag Tokyo, 1999 (17 pages).
U.S. Appl. No. 09/486,977, Office Action dated Sep. 7, 2005 (7 pages).
U.S. Appl. No. 11/780,759, Applicant's Mar. 31, 2011 Response to Office Action dated Jan. 5, 2010 (15 pages).
U.S. Appl. No. 11/780,759, Applicant's Oct. 25, 2010 Response to Office Action dated Jul. 26, 2010 (13 pages).
U.S. Appl. No. 11/780,759, Office Action dated Jan. 5, 2011 (7 pages).
U.S. Appl. No. 11/780,759, Office Action dated Jul. 22, 2010 (5 pages).
U.S. Appl. No. 11/780,759, Office Action dated Jul. 26, 2010 (7 pages).
U.S. Appl. No. 11/929,938, Office Action dated Jan. 5, 2011 (10 pages).
U.S. Appl. No. 11/929,938, Office Action dated Jul. 30, 2010 (10 pages).
U.S. Appl. No. 11/929,940, Advisory Action dated Sep. 10, 2010 (3 pages).
U.S. Appl. No. 11/929,940, Office Action dated Dec. 30, 2009 (9 pages).
U.S. Appl. No. 11/929,940, Office Action dated Jul. 1, 2010 (12 pages).
Valle “Hysteroscopic Removal of Submucous Leiomyomas”, Journal of Gynecologic Surgery, vol. 6, No. 1, pp. 89-96, 1990 (9 pages).
Weck “A Direct Path to Diagnostic and Operative Control: The Weck-Baggish Hysteroscopy System” Advertisement, Journal of Gynecologic Surgery, vol. 7, No. 1, 1991 (2 pages).
Williamson et al., Editorial 1 “Complications of hysteroscopic treatments of menorrhagia”, British Journal of Anesthesia, vol. 77, No. 3, pp. 305-308, 1996 (4 pages).
Reexamination No. 95/002,058, Patent Owner's May 5, 2015 Appeal Brief (47 pages).
Reexamination No. 95/002,058, Third Party's Jun. 5, 2015 Respondent Brief (21 pages).
Reexamination No. 95/002,058, Patent Owner's Jul. 1, 2015 Corrected Appeal Brief (47 pages).
Reexamination No. 95/002,058, Third Party's Jul. 24, 2015 Resubmitted Respondent Brief (21 pages).
Reexamination No. 95/002,058, Examiner's Answer dated Sep. 17, 2015 (3 pages).
Reexamination No. 95/002,058, Patent Owner's Oct. 19, 2015 Rebuttal Brief (25 pages).
Reexamination No. 95/001,933, Patent Owner's Apr. 24, 2015 Rebuttal Brief (8 pages).
Notification on Results of Patentability Examination for Russian Application No. 2013119298/14(028553), dated Jan. 14, 2016, 8 pages, with English language translation.
Notification of Second Office Action issued in corresponding Chinese Application No. 201611020781.6 dated Jun. 1, 2018, 18 pages with English translation.
Related Publications (1)
Number Date Country
20150374221 A1 Dec 2015 US
Continuations (1)
Number Date Country
Parent 12892355 Sep 2010 US
Child 14846198 US